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DIABETES-INSULIN-GLUCAGON-GASTROINTESTINAL

Stephanie R. Thorn,* Timothy R. H. Regnault,* Laura D. Brown, Paul J. Rozance,
Jane Keng, Michael Roper, Randall B. Wilkening, William W. Hay, Jr.,
and Jacob E. Friedman
Departments of Pediatrics (S.R.T., T.R.H.R., L.D.B., P.J.R., J.K., M.R., R.B.W., W.W.H., J.E.F.) and Biochemistry and
Molecular Genetics (J.E.F.), University of Colorado Denver, Aurora, Colorado 80045

Expression of key metabolic genes and proteins involved in mRNA translation, energy sensing, and
glucose metabolism in liver and skeletal muscle were investigated in a late-gestation fetal sheep
model of placental insufficiency intrauterine growth restriction (PI-IUGR). PI-IUGR fetuses weighed
55% less; had reduced oxygen, glucose, isoleucine, insulin, and IGF-I levels; and had 40% reduction
in net branched chain amino acid uptake. In PI-IUGR skeletal muscle, levels of insulin receptor were
increased 80%, whereas phosphoinositide-3 kinase (p85) and protein kinase B (AKT2) were reduced by 40%. Expression of eukaryotic initiation factor-4e was reduced 45% in liver, suggesting
a unique mechanism limiting translation initiation in PI-IUGR liver. There was either no change
(AMP activated kinase, mammalian target of rapamycin) or a paradoxical decrease (protein phosphatase 2A, eukaryotic initiation factor-2␣) in activation of major energy and cell stress sensors in
PI-IUGR liver and skeletal muscle. A 13- to 20-fold increase in phosphoenolpyruvate carboxykinase
and glucose 6 phosphatase mRNA expression in the PI-IUGR liver was-associated with a 3-fold
increase in peroxisome proliferator-activated receptor-␥ coactivator-1␣ mRNA and increased phosphorylation of cAMP response element binding protein. Thus PI-IUGR is-associated with reduced
branched chain amino acid uptake and growth factors, yet up-regulation of proximal insulin signaling
and a marked increase in the gluconeogenic pathway. Lack of activation of several energy and stress
sensors in fetal liver and skeletal muscle, despite hypoxia and low energy status, suggests a novel
strategy for survival in the PI-IUGR fetus but with potential maladaptive consequences for reduced
nutrient sensing and insulin sensitivity in postnatal life. (Endocrinology 150: 3021–3030, 2009)

ntrauterine growth restriction (IUGR) is a significant cause of
fetal and neonatal mortality and morbidity (1, 2). Considerable experimental animal and human epidemiological data indicate that IUGR fetuses and neonates are strongly predisposed
to the development of obesity, diabetes, and cardiovascular disease in later life (3–5). It has been hypothesized that an inadequate supply of nutrients, hypoxia, or reduced concentrations of

I

anabolic hormones might force the IUGR fetus to down-regulate
growth of certain tissues as a mechanism for survival at the expense of altered metabolic regulation in adulthood (6). Indeed,
the IUGR fetal liver is smaller relative to the brain, indicating
asymmetric growth and selective down-regulation of organ
growth (7). Moreover, increased rates of endogenous glucose
production in the fetus have been found in animal models of
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centrations, hormone levels, and fetal oxygen dynamics. Our
results indicate that the PI-IUGR fetal liver and skeletal muscle
have positive changes in the proximal insulin receptor signaling
pathway for glucose metabolism, yet unique mechanisms limiting mRNA translation, in the absence of activation of key energy
sensors. The PI-IUGR liver also has marked increases in expression of gluconeogenic genes and nuclear regulatory factors.
These data indicate that lack of fetal nutrient sensing could be an
important mechanism early in development linking IUGR to the
inability to appropriately sense and respond to changes in nutrients and metabolites and lead to excess nutrient storage, insulin resistance, and uncontrolled glucose production in postnatal life (3, 6, 28).

Materials and Methods
PI-IUGR sheep model and physiological study
Pregnant Columbia-Rambouillet ewes carrying singleton fetuses
were purchased from a commercial breeder (Nebeker Ranch, Santa
Monica, CA) and managed and studied under compliance with the Institutional Animal Care and Use Committee, University of Colorado
Denver, at the Perinatal Research Center (Aurora, CO), accredited by the
National Institutes of Health, the U.S. Department of Agriculture, and
the American Association for Accreditation of Laboratory Animal Care.
PI-IUGR fetuses were created by exposing pregnant ewes to elevated
ambient temperature (40 C for 12 h, 35 C for 12 h) from about 38 d
gestation age (dGA, term ⫽ ⬃147 dGA) to 120 dGA. Control fetuses
were used from pregnant ewes exposed to normal ambient temperatures
daily (25 C) during gestation and pair fed to the food intake of the
PI-IUGR ewes. One control animal was not included in the physiological
studies due to catheter failure.
At approximately 127 dGA, ewes underwent surgery for placement
of fetal and maternal catheters as previously described (9, 29). At approximately 134 dGA, under normal ambient conditions, fetal measurements were collected. Four sets of blood samples were drawn simultaneously from the umbilical vein and fetal artery at 20-min intervals
after reaching steady state. Umbilical blood flows were determined by
the steady-state ethanol diffusion method (29 –31). Umbilical oxygen,
glucose, and amino acid uptake rates were calculated using the Fick
principle, and the umbilical glucose-oxygen quotient was calculated
as the molar ratio of the umbilical lactate and O2 uptake multiplied
by 6 (32, 33).
At the end of the measurement period, ewes were euthanized, and the
gravid uterus was removed and dissected into fetal and placental components. Fetuses were weighed and crown-rump length measured (34).
Fetal liver and brain were weighed. The fetal ponderal index [fetal weight
(grams)/ crown-rump length3) (cubic centimeres)] and fetal brain/liver
ratio [brain weight (grams) to liver weight (grams)] were calculated. A
biopsy of fetal liver and biceps femoris skeletal muscle was removed
immediately and snap frozen in liquid nitrogen for later use.

Analysis of blood samples
Blood samples were analyzed for hematocrit, pH, PO2 and PCO2,
oxygen saturation, and oxygen contest using a blood gas analyzer (9, 35).
Ethanol concentrations were determined using a quantitative enzymatic
UV determination method (29 –31). Insulin was assayed from a pooled
sample of the four steady-state draws using an ovine insulin ELISA kit
(Alpco, Windham, NH). Plasma IGF-I was measured from the same
pooled sample by RIA after extraction (Diagnostics Systems Laboratories, Inc., Webster, TX) (36). BCAA concentrations were determined in
each of the four steady-state samples with a Dionex HPLC amino acid
analyzer (Dionex, Sunnyvale, CA) (30).
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IUGR and preterm human infants (8 –10). These altered developmental patterns, if persistent into postnatal life, may well play
an important role in the evolution of insulin resistance, diabetes,
and predisposition to metabolic disease later in life in IUGR
offspring (4, 6, 11).
Insulin is a major regulator of hepatic metabolism, including
protein synthesis, glycogen synthesis, gluconeogenesis, and
amino acid metabolism, processes that are required for normal
organ growth and development. The cellular signals downstream from the insulin receptor (IR) and insulin receptor substrate proteins (IRS)-1/2 that control growth and metabolism
include activation of the phosphoinositide 3-kinase (PI3K) and
protein kinase B (AKT) pathways and the classic p44/p42 MAPK
(ERK1/2) signaling cascade (12). Both pathways play an important role in activating mammalian target of rapamycin (mTOR),
a major energy sensor that controls both mRNA translation and
provides negative feedback to the insulin signaling cascade
through inhibition of IRS1/2 (13, 14). Downstream from
mTOR, mRNA translation initiation is controlled by regulation
of eukaryotic initiation factor (eIF)4e, eIF4e binding protein
(4EPB1), and p70 ribosomal protein S6 kinase (S6K) (14, 15).
These pathways are highly regulated and sensitive to changes in
oxygen, nutrient status, and cell stress via input from several
major energy and stress sensors including AMP-activated protein kinase (AMPK), eIF(2␣), and protein phosphatase 2A
(PP2A) (16 –18).
Recently it was reported in our sheep model of placental insufficiency IUGR (PI-IUGR) that late gestation PI-IUGR fetal
sheep have increased expression of gluconeogenic enzymes, including phosphoenolpyruvate carboxykinase (PEPCK) and
glucose-6-phosphatase (G6P), along with increased rates of hepatic glucose production compared with control fetuses (9).
PEPCK gene transcription is regulated by several key transcription factors, including cAMP response element binding
protein (CREB), members of the CCAAT/enhancer binding
protein (C/EBP) family (C/EBP␣ and C/EBP␤), and the transcriptional coactivator peroxisome proliferator-activated receptor-␥ coactivator (PGC)-1␣ (19 –21). Importantly, CREB activation can also control gluconeogenesis in the longer term by
increasing PGC1␣ expression (22). Sirtuin 1 (SIRT1), a nicotinamide adenine dinucleotide oxidation-dependent deacetylase, is
another nutrient sensitive factor regulating metabolic processes
such as gluconeogenesis and muscle fatty acid oxidation (21,
23–25). In addition to insulin, which acutely suppresses PEPCK
transcription and gluconeogenesis, AMPK activation can also
inhibit PEPCK expression and hepatic glucose production (26,
27). Consequently, impaired nutrient sensing through reduced
SIRT1 or AMPK activity could be involved in up-regulation of
hepatic glucose production in the PI-IUGR fetus.
We hypothesized that changes in key regulatory proteins involved in insulin signaling, nutrient sensing, and mRNA translation initiation are responsible for reduced fetal growth and
increased hepatic glucose production rates in the PI-IUGR fetus.
To evaluate this, we measured the expression of key proteins and
mRNA transcripts regulating these pathways in the liver and
skeletal muscle of late gestation PI-IUGR fetal sheep. We also
measured fetal branched-chain AA (BCAA) uptakes and con-
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Protein preparation and western immunoblotting

RNA isolation and real-time PCR
RNA was isolated from powdered liver tissue (30 –50 mg) using Qiazol and the RNeasy minikit with on-column deoxyribonuclease I treatment (QIAGEN, Valencia, CA). Quality and integrity of RNA was de-
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termined using the Experion RNA system (Bio-Rad, Hercules, CA).
Reverse transcriptase reactions were prepared using 2 g of RNA and
Superscript III RT with random hexamers (Invitrogen, Carlsbad, CA).
Real-time PCR primers and assays were optimized for PEPCK, PGC1␣,
SIRT1, yin-yang transcription factor 1 (YY1), estrogen receptor-related
protein (ERR)␣, cytochrome C oxidase (CYTOC), IR-A, IR-B, and 18S
rRNA as shown in supplemental Table 1, published as supplemental data
on The Endocrine Society’s Journals Online web site at http://endo.
endojournals.org. A previously validated assay for G6P was used (9).
Real-time PCRs were performed using 20 ng of diluted cDNA (2 ng for
18S assay), 500 nM of each primer (200 nM for 18S), and SYBR Green
PCR mix (AbGene Thermo Fisher Scientific, Rockford, IL) on the iCycler
iQ5 real time PCR instrument (Bio-Rad). A relative standard curve of
pooled liver cDNA was generated (six standards prepared as 4-fold serial
dilutions) and used for quantification of unknown sample expression.
Results were adjusted to 18S expression and expressed relative to the
average of the control group for each gene.

Hepatic glycogen measurements
Hepatic glycogen concentration was determined as previously described (9). Results are expressed as milligrams glycogen per gram wet
weight liver tissue.

Statistical analysis
Student’s t test for unpaired samples after F test for equality of variance between treatments was used to analyze physiological, protein expression, and gene expression data between the control and PI-IUGR
group. If F test was significant, data were analyzed using a Student’s t test
for unpaired samples with unequal variance. Statistical significance was
declared at P ⬍ 0.05, and P ⬍ 0.10 is indicated as statistical tendencies.

Results
Fetal characteristics in PI-IUGR
Fetuses in both groups were of similar gestational ages at
study (133 dGA control vs. 134 dGA PI-IUGR). The PI-IUGR
fetuses weighed 55% less (Table 1) and had a 60% reduction in
liver weight compared with control fetuses (42.8 ⫾ 5.2 PI-IUGR
vs. 112.3 ⫾ 6.4 g control, P ⬍ 0.001). The ponderal index was
similar between both groups, yet the brain to liver ratio was
significantly increased in the PI-IUGR fetuses (Table 1). Fetal
arterial blood oxygen content, saturation, and partial pressure
were reduced in the PI-IUGR fetuses (Table 1). Umbilical blood
flow was decreased by approximately 35% in PI-IUGR fetuses
(Table 1). Umbilical (net fetal) oxygen uptake rate also was reduced by 25% in PI-IUGR fetuses (Table 1). The PI-IUGR fetuses
were hypoglycemic and hypoinsulinemic and had reduced circulating IGF-I concentrations (Table 1). Lactate concentrations
and the umbilical glucose-oxygen quotient were not significantly
different between the two groups (Table 1).
PI-IUGR is associated with reduced branched chain
amino acid uptake and arterial concentrations
The umbilical (net fetal) uptake rate of all three BCAA was
significantly reduced in PI-IUGR compared with control fetuses
(Table 1). Arterial concentrations of valine and leucine were not
significantly different between the two groups, but isoleucine
concentration was significantly reduced in the PI-IUGR group
(Table 1).
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For whole-cell extracts, liver or muscle tissue (200 mg) was lysed and
homogenized in 2 ml of cell lysis buffer containing 20 mM Tris, 150 mM
MgCl2, 1% Triton, 2 mM EDTA, 20 mM ␤-glycerophosphate, and protease and phosphatase inhibitors [2.5 mM NaPP, 10 mM NaF, 1 mM
phenylmethylsulfonyl fluoride, 2 g/ml aprotinin, 2 g/ml leupeptin,
and 2 g/ml pepstatin, and 1⫻ phosphatase inhibitor cocktails 1 and 2
(Sigma, St. Louis, MO)]. Homogenates were incubated on ice and cleared
by centrifugation. For nuclear enriched protein extracts, liver tissue (50
mg) was lysed and homogenized in 0.5 ml of lysis buffer containing 25
mM Tris, 10 mM KCl, 1.5 mM MgCl2, 0.5 mM dithiothreitol, and protease
and phosphatase inhibitors. The homogenates were incubated on ice for
10 min and centrifuged at 4000 ⫻ g for 10 min. The supernatant was
removed and the nuclear pellet was sonicated in 0.25 ml of nuclear lysis
buffer containing 50 mM Tris, 400 mM NaCl, 1.5 mM MgCl2, 0.5 mM
dithiothreitol, 0.2 mM EDTA, and protease and phosphatase inhibitors.
Nuclear lysates were cleared by centrifugation.
Protein concentrations were determined using a bicinchoninic acid
protein assay (Pierce, Rockford, IL). Protein samples (40 –75 g) were
electrophoresed in 10% polyacrylamide gels and transferred to polyvinylidene fluoride or nitrocellulose membranes. Membranes were
blocked in Tris-buffered saline containing 1% Tween 20 (TBS-T) and
5% milk for at least 1 h and then transferred to primary antibody solutions and incubated overnight. Membranes were washed three times in
TBS-T, incubated with the appropriate horseradish peroxidase-conjugated secondary antibody for 1 h, washed five times with TBS-T, and
detected using horseradish peroxidase-mediated chemiluminescence and
autoradiography. Primary antibodies against IR-␤, IRS-2, IRS-1, SIRT1,
hepatocyte nuclear factor (HNF)-4␣, C/EBP␣, and C/EBP␤ were purchased from Santa Cruz Biotech (Santa Cruz, CA); antibodies against
regulatory subunit of PI3K (p85), AKT1, AKT2, and laminin A/C were
purchased from Upstate (Billerica, MA); antibodies against phosphorylated AKT (S473), mTOR, phosphorylated mTOR (S2448), AMPK,
phosphorylated AMPK (T172), eIF2␣, phosphorylated eIF2␣ (S51),
S6K, phosphorylated S6K (S421/T424), ERK1/2, phosphorylated
ERK1/2 (T202/Y204), regulatory subunit of PP2A(R), catalytic subunit
of PP2A(C), PGC1␣, CREB, and phosphorylated CREB (S133) were
purchased from Cell Signaling (Beverly, MA); antibody against glycogen synthase kinase (GSK)-3␤ was purchased from BD Biosciences
(San Jose, CA); and an antibody against ␤-actin was purchased from
Mediummune (Gaithersburg, MD). The majority of these antibodies
have been used previously in sheep samples (9, 37–39); for those that had
not been, we observed immunoreactive signal at the expected molecular
weight, indicating specificity.
Protein expression was quantified using scanned images and densitometric analyses (Scion Image Software, Frederick, MD). Data for each
protein sample were expressed relative to the mean of the control group.
For phosphorylated proteins, a ratio of the phosphorylated and total
protein data were calculated. To evaluate for equal protein loading,
␤-actin (whole cell extracts) or laminin A/C (nuclear extracts) protein
expression was determined and expression was invariant. For liver
whole-cell extract samples, five control and eight PI-IUGR samples were
prepared and at least four were run on each gel. For liver nuclear enriched
extracts, only three control and five PI-IUGR fetal liver samples were
prepared due to limited availability of tissue samples, and all were run on
each gel. For muscle whole-cell extract samples, seven control and nine
PI-IUGR samples were prepared, and at least five were run on each gel,
as indicated in figure legends. In some cases, two gels were run to accommodate the number of samples, and in these cases, expression on
each blot is relative to an internal control sample that was run on each
gel. Experiments were performed at least twice for each antibody. Representative results are shown.
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TABLE 1. Fetal measurements and metabolic parameters in late-gestation control and PI-IUGR fetal sheep
Variable

PI-IUGR

P value

392.4 ⫾ 31.5
3796.9 ⫾ 117.8
0.42 ⫾ 0.03
3.39 ⫾ 0.25

154.8 ⫾ 19.1
1680.4 ⫾ 178.2
1.06 ⫾ 0.12
2.83 ⫾ 0.19

⬍0.0001
⬍0.001
NS

0.35 ⫾ 0.01
7.370 ⫾ 0.004
3.15 ⫾ 0.19
49.23 ⫾ 1.85
18.96 ⫾ 0.64
47.22 ⫾ 0.57
1.14 ⫾ 0.05
0.56 ⫾ 0.03
2.03 ⫾ 0.09
0.43 ⫾ 0.10
54.5 ⫾ 11.6
462.0 ⫾ 28.0
165.2 ⫾ 6.5
106.5 ⫾ 5.3

0.37 ⫾ 0.02
7.330 ⫾ 0.020
1.38 ⫾ 0.21
22.31 ⫾ 3.02
12.03 ⫾ 0.76
51.38 ⫾ 0.62
0.71 ⫾ 0.05
0.59 ⫾ 0.02
4.71 ⫾ 1.26
0.19 ⫾ 0.05
10.7 ⫾ 3.2
414.7 ⫾ 30.5
174.0 ⫾ 15.6
82.3 ⫾ 7.8

NS
NS
⬍0.001
⬍0.001
⬍0.001
⬍0.001
⬍0.001
NS
NS
⬍0.05
⬍0.001
NS
NS
⬍0.05

211.3 ⫾ 11.9
0.35 ⫾ 0.03
5.08 ⫾ 0.98
4.80 ⫾ 0.52
3.10 ⫾ 0.34

145.3 ⫾ 5.9
0.28 ⫾ 0.01
2.66 ⫾ 0.31
3.05 ⫾ 0.18
1.67 ⫾ 0.11

⬍0.001
⬍0.05
⬍0.05
⬍0.05
⬍0.01

Values are means ⫾ SE for six control and 12 PI-IUGR fetuses. NS, Nonsignificant P value (P ⬎ 0.05).

PI-IUGR is associated with select changes in the
proximal insulin signaling cascade
Protein expression changes in the fetal liver and skeletal muscle are summarized in Table 2. In the PI-IUGR fetal liver, ex-

pression of IR-␤ protein tended to be higher (Fig. 1A). Relative
mRNA abundance for the IR-B transcript also tended to be increased by 50% (1.00 ⴞ 0.09 control vs. 1.48 ⫾ 0.21 PI-IUGR,
P ⫽ 0.06), and there was no change in IR-A transcript abundance

TABLE 2. Summary of protein expression in liver and skeletal muscle in late-gestation control and PI-IUGR fetal sheep
Liver
Protein
Proximal insulin signaling
IR-␤
IRS-1/2
p85␣
GSK3␤
AKT1
AKT2
Protein synthesis
ERK1/2
P-ERK1/2
mTOR
P-mTOR
4EBP1
eIF4E
S6K
Nutrient sensing and stress
AMPK
P-AMPK
eIF2␣
P-eIF2␣
PP2AC
PP2AR

Skeletal muscle

Control

PI-IUGR

P value

Control

PI-IUGR

P value

1.00 ⫾ 0.13
1.00 ⫾ 0.10
1.00 ⫾ 0.04
1.00 ⫾ 0.21
1.00 ⫾ 0.39
1.00 ⫾ 0.08

1.43 ⫾ 0.16
0.78 ⫾ 0.20
0.86 ⫾ 0.09
0.38 ⫾ 0.03
0.86 ⫾ 0.19
1.00 ⫾ 0.10

0.07
NS
NS
0.06
NS
NS

1.00 ⫾ 0.17
1.00 ⫾ 0.05
1.00 ⫾ 0.08
1.00 ⫾ 0.02
1.00 ⫾ 0.03
1.00 ⫾ 0.13

1.80 ⫾ 0.30
1.00 ⫾ 0.20
0.64 ⫾ 0.11
0.77 ⫾ 0.19
0.93 ⫾ 0.03
0.63 ⫾ 0.07

⬍0.05
NS
⬍0.05
NS
NS
⬍0.05

1.00 ⫾ 0.05
1.00 ⫾ 0.27
1.00 ⫾ 0.04
1.00 ⫾ 0.14
1.00 ⫾ 0.20
1.00 ⫾ 0.19
1.00 ⫾ 0.15

0.911 ⫾ 0.05
1.201 ⫾ 0.22
1.080 ⫾ 0.08
1.130 ⫾ 0.09
2.500 ⫾ 0.63
0.380 ⫾ 0.07
0.970 ⫾ 0.15

NS
NS
NS
NS
0.06
⬍0.05
NS

1.00 ⫾ 0.04
1.00 ⫾ 0.09
1.00 ⫾ 0.35

1.02 ⫾ 0.03
1.16 ⫾ 0.19
1.55 ⫾ 0.51

NS
NS
NS

1.00 ⫾ 0.28
1.00 ⫾ 0.33
1.00 ⫾ 0.08

0.99 ⫾ 0.20
1.31 ⫾ 0.23
0.99 ⫾ 0.11

NS
NS

1.00 ⫾ 0.05
0.98 ⫾ 0.27
1.00 ⫾ 0.13
1.01 ⫾ 0.12
1.00 ⫾ 0.09
1.00 ⫾ 0.04

0.75 ⫾ 0.11
2.04 ⫾ 0.36
1.12 ⫾ 0.21
0.54 ⫾ 0.33
0.47 ⫾ 0.10
0.94 ⫾ 0.03

NS
NS
NS
NS
⬍0.005
NS

1.00 ⫾ 0.04
1.00 ⫾ 0.12
1.00 ⫾ 0.12
1.00 ⫾ 0.14
1.00 ⫾ 0.14
1.00 ⫾ 0.08

0.91 ⫾ 0.11
1.12 ⫾ 0.10
1.07 ⫾ 0.12
0.22 ⫾ 0.03
0.93 ⫾ 0.07
0.78 ⫾ 0.07

NS
NS
NS
⬍0.001
NS
⬍0.05

IRS-2 was measured in liver and IRS-1 was measured in skeletal muscle. Phosphorylation of proteins (P) is expressed as a ratio of phosphorylated to total levels as indicated in
Material and Methods. Number of animals studied in each group is indicated in figure legends. Values are means ⫾ SE. NS, Nonsignificant P value (P ⬎ 0.05).
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Fetal growth parameters
Placenta weight, g
Fetal weight, g
Brain to liver ratio
Ponderal index, g/cm3
Fetal arterial measurements
Hematocrit
pH
O2 content, mmol/liter
O2 saturation, %
PO2, mm Hg
PCO2, mm Hg
Glucose, mM
Glucose-oxygen quotient
Lactate, mM
Insulin, ng/ml
IGF-I, ng/ml
Valine, nmol/ml
Leucine, nmol/ml
Isoleucine, nmol/ml
Umbilical blood flow and uptakes
Blood flow, ml/min 䡠 kg
Oxygen uptake, mol/min 䡠 kg
Valine uptake, mol/min 䡠 kg
Leucine uptake, mol/min 䡠 kg
Isoleucine uptake, mol/min 䡠 kg

Control

Endocrinology, July 2009, 150(7):3021–3030

in the PI-IUGR compared with control fetal liver (1.00 ⫾ 0.05
control vs. 1.21 ⫾ 0.18 PI-IUGR). The expression of the proximal insulin signaling proteins, IRS-2 and p85␣, was similar between the control and PI-IUGR liver (Fig. 1A). However,
GSK3␤, a negative regulator of insulin signaling, tended to be
reduced by 60% in the PI-IUGR liver (Fig. 1A). The expression
of the AKT1 and AKT2 proteins was similar between the control
and PI-IUGR liver (Fig. 1A), and there was no change in basal
AKT phosphorylation (serine 473, data not shown).
Compared with control fetuses, PI-IUGR fetal skeletal muscle
had an 80% increase in the level of IR-␤ with no change in IRS-1
levels (Fig. 1B). Levels of p85␣ were reduced by 36% in PI-IUGR
fetal skeletal muscle (Fig 1B). AKT2 levels were also reduced by
37% in the PI-IUGR compared with control fetal skeletal muscle,
yet there were no significant differences in the levels of GSK3␤ or
AKT1 (Fig 1B).
PI-IUGR alters expression and phosphorylation of
proteins involved in mRNA translational initiation
We next evaluated the expression of proteins more distal in
the insulin signaling pathway that are involved in the control of
mRNA translation initiation. Phosphorylation of ERK1/2 protein and total levels of ERK1/2 protein were unchanged in the
PI-IUGR compared with control fetal liver (Fig. 2A). The total
levels of mTOR protein were also unchanged in the PI-IUGR
fetal liver (Fig. 2A). The activity of mTOR, assessed by phosphorylation status, was similar between the control and PI-IUGR
fetal liver (Fig 2A). Total levels of S6K were also unchanged (Fig.
2A). The protein expression of the translation initiation factor
eIF4E was reduced by 60% in the PI-IUGR liver (Fig. 2A). The mean
expression of 4EBP1, a binding protein and inhibitor of eIF4E, was
increased by over 2-fold, although this failed to reach statistical
significance (Fig. 2A). Thus, PI-IUGR fetuses may limit mRNA
translation initiation in the liver by reducing levels of eIF4E and
increasing levels of its inhibitor, 4EBP1.
In fetal skeletal muscle, there was no change in expression of
ERK1/2 or mTOR or in phosphorylation of ERK1/2 (Fig. 2B).
Phosphorylated mTOR protein was below the limits of detection by
western blotting in fetal skeletal muscle. Moreover, levels of S6K,
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FIG. 2. Expression of proteins involved in protein synthesis in control and
growth-restricted (PI-IUGR) fetal liver and skeletal muscle. The protein expression
of ERK1/2, mTOR, 4EBP1, eIF4E, and S6K was measured by Western blotting
using whole-cell extracts prepared from late-gestation control and PI-IUGR fetal
(A) liver and (B) skeletal muscle tissue samples. Phosphorylation of ERK1/2 (P-ERK,
T202/Y204), mTOR (P-mTOR, S2448), and S6K (P-S6K, S421/T424) was also
measured. Western blot results were quantified and analyzed for control (n ⫽
4 –5) and PI-IUGR (n ⫽ 4 – 8) fetal liver samples and for control (n ⫽ 5–7) and
PI-IUGR (n ⫽ 6 – 8) fetal skeletal muscle as shown in Table 1. Representative
images are shown for three control and three PI-IUGR samples.

eIF4E, and 4EBP1 were unchanged (Fig. 2B), indicating that
PI-IUGR had no effect on the levels of the effector proteins upstream
or downstream of the mTOR pathway in fetal skeletal muscle.
Impaired nutrient and oxygen sensing signals in the
PI-IUGR fetal liver and skeletal muscle
A major mechanism for sensing nutrient deprivation and hypoxia and thereby inhibiting protein translation initiation is the
activation of AMPK. Both total and phosphorylated levels of
AMPK protein were similar in the PI-IUGR compared with control fetal liver (Fig. 3A). Surprisingly, levels of phosphorylated
eIF2␣, a marker of endoplasmic reticulum stress, were paradoxically reduced in the PI-IUGR liver by 60%, whereas the total
levels of eIF2␣ were unchanged (Fig. 3A). Also, the expression of
stress kinase catalytic subunit PP2AC, a negative regulator of
translation initiation, was reduced by 50%, with no change in
expression of the regulatory subunit (PP2AR, Fig 3A).
In fetal skeletal muscle, there was no change in phosphorylation or expression of AMPK (Fig. 3B). Phosphorylated eIF2␣
protein was reduced by 75% in PI-IUGR skeletal muscle (Fig.

FIG. 3. Expression of nutrient and stress sensors in control and growth-restricted
(PI-IUGR) fetal liver and skeletal muscle. The protein expression of AMPK, eIF2a,
PP2AR, and PP2AC was measured by Western blotting using whole-cell extracts
prepared from late-gestation control and PI-IUGR fetal liver (A) and muscle (B)
tissue samples. Phosphorylation of AMPK (P-AMPK, T172) and eIF2␣ (P-eIF2␣,
S51) was also measured. Western blot results were quantified and analyzed for
control (n ⫽ 4 –5) and PI-IUGR (n ⫽ 4 – 8) fetal liver samples and for control (n ⫽
5–7) and PI-IUGR (n ⫽ 6 – 8) fetal skeletal muscle as shown in Table 1.
Representative images are shown for three control and three PI-IUGR samples.
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FIG. 1. Expression of components in the proximal insulin-signaling pathway in
control and growth-restricted (PI-IUGR) fetal liver and skeletal muscle. The
protein expression of IR-␤, p85, IRS-2 (liver) or IRS-1 (muscle), GSK-3␤, AKT1,
and AKT2 was measured by Western blotting using whole-cell extracts prepared
from late-gestation control and PI-IUGR fetal (A) liver and (B) skeletal muscle
tissue samples. Western blot samples were quantified and analyzed for control
(n ⫽ 4 –5) and PI-IUGR (n ⫽ 4 – 6) fetal liver samples and for control (n ⫽ 5–7)
and PI-IUGR (n ⫽ 6 – 8) fetal skeletal muscle as shown in Table 1. Representative
images are shown for three control and three PI-IUGR samples.
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PI-IUGR induces gluconeogenic genes and related
nuclear factors in fetal liver
PEPCK mRNA abundance was increased 20-fold and G6P
expression increased 13-fold in the PI-IUGR fetal liver (Fig. 4A).
The mRNA abundance of PGC1␣ was also increased 3-fold (Fig.
4A). The expression of CYTOC, a transcriptional target of
PGC1␣, was increased by nearly 2-fold (Fig 4A); however, there
was no change in ERR␣ or YY1 expression, other downstream
target targets of PGC1␣ (40). The mRNA abundance for the
PGC1␣ activator SIRT1 was unchanged in the PI-IUGR fetal
liver (Fig 4A). Furthermore, hepatic glycogen content was similar
between the PI-IUGR and control fetuses (45.9 ⫾ 6.8 mg/g PIIUGR vs. 37.6 ⫾ 4.8 mg/g control), suggesting fetal gluconeogenesis rather than glycogenolysis.

FIG. 4. Relative mRNA abundance and nuclear protein expression of
gluconeogenic and regulatory genes in control and growth-restricted (PI-IUGR)
fetal liver. A, The mRNA abundance for PEPCK, G6P, PGC1␣, SIRT1, YY1, ERR␣,
and CYTOC was determined by real-time PCR. Results were adjusted for 18S
rRNA abundance and expressed relative to the average of the control group (n ⫽
5 control, n ⫽ 9 PI-IUGR fetal liver samples). Means ⫾ SEM are shown for each
group. B, The protein expression of SIRT1, PGC1␣, HNF4␣, C/EBP␤, C/EBP␣,
CREB, and phosphorylated CREB (P-CREB, S133) was measured by Western
blotting using nuclear extracts prepared from late-gestation control and PI-IUGR
fetal liver tissue samples. The expression of lamin A/C is shown as loading
control. C, Western blot results were quantified and analyzed for control (n ⫽ 3)
and PI-IUGR (n ⫽ 5) fetal liver samples. For CREB, phosphorylation was measured
and quantification results are shown for the phosphorylated (Phos) and total
form of the protein and a ratio of the phosphorylated to total protein levels.
Means ⫾ SEM are shown for each group. *, P ⬍ 0.05; #, P ⬍ 0.10.

Next, we evaluated the expression of these and other key
gluconeogenic regulatory factors at the protein level in liver
whole-cell and nuclear extracts prepared from control and PIIUGR fetal livers. PGC1␣ expression was 3-fold higher in nuclear extracts from the PI-IUGR fetal liver, and phosphorylation
of CREB was more than 2-fold higher in both whole-cell and
nuclear extracts from the PI-IUGR liver, whereas total levels of
CREB were similar (Fig. 4, B and C, and supplemental Fig. 1).
Expression of C/EBP␣ and C/EBP␤ also tended to be higher in
nuclear extracts, whereas expression was similar in whole-cell
extracts prepared from the PI-IUGR fetal liver (Fig. 4, B and C,
and supplemental Fig. 1). The expression of SIRT1 and HNF4␣
was similar between the control and PI-IUGR fetal liver (Fig. 4,
B and C, and supplemental Fig. 1). These data suggest that the
fetal sheep PI-IUGR liver has a robust increase in PGC1␣ and
factors that act through cAMP regulatory pathways controlling
gluconeogenesis.

Discussion
Chronic fetal nutrient deprivation during late gestation, whether
induced by placental insufficiency or maternal nutrient restriction, results in fetal growth restriction, decreased liver and skeletal muscle growth, and changes in hepatic function, including
persistently increased gluconeogenesis, that increase the postnatal risk for development of diabetes and obesity (3, 4, 6, 41). The
cellular mechanism(s) responsible in the IUGR fetus remain inadequately understood. Our results indicate that PI-IUGR is associated with decreased net fetal uptake rates of BCAA, hypoxia,
reduced IGF-I, insulin, and glucose concentrations and a specific
reduction in skeletal muscle AKT2 protein. We also found that
the PI-IUGR fetus has a unique mechanism that may limit mRNA
translation downstream of mTOR in the liver. The PI-IUGR fetal
liver and skeletal muscle also show significant changes in the
proximal insulin signaling pathway and unexpectedly no change
or, in some cases, a paradoxical decrease in expression of nutrient and energy sensors. Furthermore, we found increased expression of key nuclear regulatory factors in the liver that may be
responsible for increased glucose production in the PI-IUGR fetus. These changes may be necessary to allow the PI-IUGR fetus
to survive but may also ultimately increase the risk for diabetes.
IUGR is associated with reduced fetal BCAA uptake
The concentration of isoleucine was significantly lower in the
PI-IUGR fetal circulation, but the concentrations of leucine and
valine remained normal despite reduced net fetal uptake rates of
all three BCAAs. These data contrast with previous reports in this
model showing no change in the concentrations or net fetal uptake rates of the BCAA (42). These differences likely represent
variation in the PI-IUGR fetus due to different degrees of placental insufficiency. Maintenance of normal fetal arterial BCAA
concentrations likely represents a balance among increased
BCAA release from protein breakdown (42, 43), increased
BCAA oxidation (42), and reduced amino acid use for protein
synthesis (42). Because the BCAAs are rate limiting for protein
synthesis, this implies that reduced BCAA availability along with
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3B). Levels of the regulatory subunit of the protein phosphatase,
PP2AR, were decreased by 25%, yet levels of the catalytic subunit, PP2AC, were unchanged in PI-IUGR compared to control
fetal skeletal muscle (Fig. 3B). These data indicate that major
nutrient and oxygen-sensing mechanisms necessary for suppression of translation initiation were either not activated or changed
in the opposite direction expected in the PI-IUGR fetal liver and
skeletal muscle.
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reduced blood oxygen content and reduced plasma insulin and
IGF-I concentrations may suppress protein synthesis, leading to
reduced skeletal muscle mass and fetal growth.

Increased expression of the proximal insulin signaling
pathway
The level of IR-␤ protein was increased in PI-IUGR skeletal
muscle and tended to be increased at both the mRNA and protein
level in the liver. Up-regulation of IR-␤ is perhaps not surprising,
given the low levels of insulin in the PI-IUGR fetus. There was a
decrease in the p85␣ regulatory subunit of PI3K in PI-IUGR fetal
skeletal muscle. Decreased p85␣ is consistent with a potential for
increased glucose uptake. Decreasing any of the regulatory subunits by genetic deletion in mouse models or by small interfering
RNA in cell models leads to enhanced PI3K activity and downstream signaling (46), whereas an increase in the expression of
p85␣ reduces insulin-stimulated PI3K activity and is associated with insulin resistance (47– 49). A decrease in the p85␣
and p110 subunits has been reported in adult skeletal muscle
from a protein-restricted IUGR rat model and in adults with
low birth weight (50). Overall, the changes in IR-␤ and p85␣ are
consistent with increased peripheral insulin sensitivity to glucose
utilization observed previously in the PI-IUGR fetus in utero
during a hyperglycemic clamp (9).
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The decrease in AKT2 in the PI-IUGR fetal skeletal muscle is
consistent with studies showing a distinct role of AKT2 on skeletal muscle differentiation and myogenesis (51–53). AKT1 is
required for proliferation, whereas AKT2 promotes cell cycle
exit (54). During differentiation in vitro and during regeneration
in vivo, AKT2 expression and activity are markedly induced,
suggesting a possible role of AKT2 during muscle proliferation
(52, 55, 56). Indeed, in human skeletal muscle, IRS-1 and AKT2
are required for myoblast differentiation and glucose metabolism, whereas IRS-2 and AKT1 was used for lipid metabolism
(57). Similarly, in AKT2 knockout mice, there is mild growth
deficiency but also age-dependent loss of adipose tissue and severe diabetes, with neither AKT1 nor AKT3 knockout mice
showing similar defects (58). These studies suggest that AKT2
down-regulation in fetal skeletal muscle in the PI-IUGR model
could be an important factor limiting skeletal muscle growth in
utero. This decrease may also be tissue specific because levels of
AKT1 and AKT2 were not affected in the liver of the PI-IUGR
fetus and unrelated to changes in skeletal muscle glucose metabolism because normal glucose-stimulated glucose utilization
rates in the PI-IUGR fetus have been reported (9).
Impaired nutrient sensing in PI-IUGR fetus
One of the novel findings of the present study is that the
late-gestation PI-IUGR fetus demonstrates a failure to activate
major energy and stress sensors, including AMPK, mTOR, and
SIRT1, and decrease in the levels of the stress kinase PP2A and
eIF2␣. These results may seem paradoxical, given that the fetus
is exposed to hypoxia, and reduced glucose and anabolic hormones, but likely represent a unique adaptive mechanism. In the
short-term, the regulation of protein phosphorylation by kinases
and phosphatases is an important mechanism in the control of
the apoptotic cell death program. For example, cells lacking nutrients suppress mTOR activity via AMPK activation and can
also activate the autophagy machinery via SIRT1 activation and
mTOR inhibition. These mechanisms provide cells with a source
of energy, thereby enhancing cell survival during the stress (13,
17, 59, 60). In the long-term, however, chronic nutrient stress in
cell culture systems through the activation of AMPK, PP2A, or
eIF2␣ has been demonstrated to result in apoptosis and cell death
(61, 62). Collectively, this suggests that the adaptations that we
have shown in the PI-IUGR fetus may be important mechanism
for survival outcome.
The decreased ability of the PI-IUGR fetus to activate cell
nutrient and stress sensing pathways, however, could have important negative implications for the development of diabetes
later in life if this change persists postnatally. For example,
AMPK activation is linked to fatty acid oxidation through phosphorylation of acetyl CoA carboxylase (17, 63). AMPK activation also can reduce gluconeogenesis and PEPCK transcription
via phosphorylation and nuclear removal of transducer of regulated CREB-2 and phosphorylation of GSK3␤ (26, 27). The
inability of AMPK to suppress mTOR activity has been shown to
lead to endoplasmic reticulum stress, apoptosis, and impaired
insulin action (16). These data, together with our observations of
normal hepatic glycogen levels in the PI-IUGR fetus despite low
glucose supply and circulating glucose and insulin concentra-
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Decreased protein translation initiation
mTOR regulates cell growth by sensing upstream nutrient
and hormonal signals to coordinate gene activation, protein synthesis, and cell growth (13, 14). mTOR phosphorylates 4EBP1
and S6K, which increases mRNA translation (13, 14). Interestingly, we found that despite nutrient and oxygen deprivation,
mTOR phosphorylation was unchanged in the PI-IUGR fetal
liver and undetectable in the PI-IUGR skeletal muscle. Likewise,
the immediate upstream inputs that control mTOR activity, such
as AMPK and AKT, were unchanged. The initiation phase of
mRNA translation is a pivotal site of regulation for global rates
of protein synthesis as well as a site through which the synthesis
of specific proteins is controlled. The abundance of eIF4e, which
is rate limiting relative to other components in the eIF4 complex,
was reduced in the PI-IUGR liver and could be an important
mechanism limiting translation initiation (44). Thus, our observations of increased 4EBP1 combined with reduced eIF4e could
serve to limit mRNA translation initiation and growth in the
PI-IUGR fetal liver. We did not find any changes in these proteins
in the PI-IUGR fetal skeletal muscle suggesting that tissue-specific mechanisms are involved.
Our findings are consistent with data in another model of fetal
growth restriction, showing that skeletal muscle from midgestation nutrient-restricted fetal sheep had no change in total levels
of mTOR or AMPK protein, yet contrast with the finding of
reduced phosphorylation of mTOR and a downstream target
ribosomal protein S6 (45). We did attempt to measure the phosphorylation of several proteins, including mTOR, AKT, and
S6K, but due to low basal activity levels in our fetal tissues, these
results are not measurable. Studies are underway to evaluate the
effect of insulin stimulation of these pathways.
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tions (9), suggest that there may be a selective adaptation in the
nutrient sensing pathways that if persistent postnatally would
result in greater capacity for nutrient storage and presumably
insulin resistance.

Summary and implications
Several studies have shown that IUGR fetal sheep have maintained or increased whole-body insulin sensitivity (9, 68, 69). In
early postnatal life, ovine IUGR offspring undergo rapid growth,
increased feeding activity, and development of adiposity in addition to maintained insulin sensitivity (70 –72). As these ovine

IUGR offspring mature, however, they have increased body
weight gain and adiposity and develop glucose intolerance (70,
73). Moreover, IUGR fetal sheep and postnatal IUGR rodents
have increased PEPCK and hepatic glucose production (9, 74,
75). These early increases in PEPCK and glucose production,
however, contrast with increased peripheral insulin sensitivity in
fetal and early postnatal life and suggest that chronically increased glucose production resulting from IUGR may contribute
to the development of insulin resistance in postnatal animals.
Future studies are underway to investigate the effect of insulin on
these pathways to better understand the impact of nutrient and
growth restriction in utero.
Overall, our data indicate that the PI-IUGR fetus has adapted
to nutrient deprivation from reduced placental nutrient transport in unique ways to ensure survival. PI-IUGR is associated
with reduced circulating hormones, decreased BCAA uptake
rates, hypoxia, and reduced AKT2 levels, all of which contribute
to reduced skeletal muscle mass and fetal growth. We also found
up-regulation of the proximal insulin signaling pathway as a
mechanism for increased glucose uptake. There is also up-regulation of nuclear regulatory factors promoting glucose production in the liver and failure to activate nutrient sensing pathways
in both liver and skeletal muscle. These adaptations in IUGR
offspring, however, may set the stage for cellular changes that
underlie the progression to insulin resistance, uncontrolled glucose production, diabetes, and increased nutrient storage in postnatal life.
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